Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
LIMBO-ATX: Dexamethasone infusion after atherectomy
NCT02479620Phase 2Unknown
- Sponsor
- Mercator MedSystems
- Start
- Jun 2016
- Primary completion
- Nov 2019
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of dexamethasone in chronic limb-threatening ischaemia (CLTI), sponsored by Mercator MedSystems. Status: unknown.
02
Drugs
dexamethasone
03
Conditions
chronic limb-threatening ischaemia (CLTI)
Beyond the preview
Go deeper on NCT02479620.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02479620.